The clinical significance of autoantibodies to the proliferating cell nuclear antigen (PCNA)

Autoimmunity Reviews

Volumn 11, Issue 10, 2012, Pages 771-775

  Mahler, Michael ^a   Miyachi, Kiyomitsu ^b   Peebles, Carol ^a   Fritzler, Marvin J ^c  

^a INOVA DIAGNOSTICS INC   (United States)

^b First Diagnostic Division   (Japan)

^c UNIVERSITY OF CALGARY   (Canada)

Author keywords

Autoantibodies; ELISA; Indirect immunofluorescence; PCNA; Systemic lupus erythematosus

Indexed keywords

AUTOANTIBODY; CELL NUCLEUS RECEPTOR; CYCLINE; DNA DIRECTED DNA POLYMERASE DELTA; TRANSCRIPTION FACTOR E2F;

AMINO ACID SEQUENCE; ANTIBODY DETECTION; ANTIBODY TITER; ANTIGEN EXPRESSION; AUTOIMMUNE DISEASE; CELL CYCLE PHASE; COMPLEX FORMATION; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOASSAY; IMMUNOFLUORESCENCE; IMMUNOFLUORESCENCE TEST; REVIEW; SYSTEMIC AUTOIMMUNE RHEUMATIC DISEASE; SYSTEMIC LUPUS ERYTHEMATOSUS;

AMINO ACID SEQUENCE; AUTOANTIBODIES; AUTOANTIGENS; BINDING SITES, ANTIBODY; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; META-ANALYSIS AS TOPIC; MOLECULAR SEQUENCE DATA; MULTIPROTEIN COMPLEXES; PROLIFERATING CELL NUCLEAR ANTIGEN;

EID: 84864391509     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2012.02.012     Document Type: Review

References (40)

1. Mahler M., Fritzler M.J. Epitope specificity and significance in systemic autoimmune diseases. Ann N Y Acad Sci 2010, 1183:267-287.
2. Gomez-Puerta J.A., Burlingame R.W., Cervera R. Anti-chromatin (anti-nucleosome) antibodies: diagnostic and clinical value. Autoimmun Rev 2008, 7:606-611.
3. Schulte-Pelkum J., Fritzler M., Mahler M. Latest update on the Ro/SS-A autoantibody system. Autoimmun Rev 2009, 8:632-637.
4. Fritzler M.J., Rattner J.B., Luft L.M., Edworthy S.M., Casiano C.A., Peebles C., et al. Historical perspectives on the discovery and elucidation of autoantibodies to centromere proteins (CENP) and the emerging importance of antibodies to CENP-F. Autoimmun Rev 2011, 10:194-200.
5. Mahler M., Raijmakers R. Novel aspects of autoantibodies to the PM/Scl complex: clinical, genetic and diagnostic insights. Autoimmun Rev 2007, 6:432-437.
6. Mahler M, Hanly JG, Fritzler MJ. Importance of the dense fine speckled pattern on HEp-2 cells and anti-DFS70 antibodies for the diagnosis of systemic autoimmune diseases. Autoimmun Rev 2011.
7. Stinton L.M., Fritzler M.J. A clinical approach to autoantibody testing in systemic autoimmune rheumatic disorders. Autoimmun Rev 2007, 7:77-84.
8. Miyachi K., Fritzler M.J., Tan E.M. Autoantibody to a nuclear antigen in proliferating cells. J Immunol 1978, 121:2228-2234.
9. Takasaki Y., Deng J.S., Tan E.M. A nuclear antigen associated with cell proliferation and blast transformation. J Exp Med 1981, 154:1899-1909.
10. Ogata K., Ogata Y., Nakamura R.M., Tan E.M. Purification and N-terminal amino acid sequence of proliferating cell nuclear antigen (PCNA)/cyclin and development of ELISA for anti-PCNA antibodies. J Immunol 1985, 135:2623-2627.
11. Takasaki Y., Kogure T., Takeuchi K., Kaneda K., Yano T., Hirokawa K., et al. Reactivity of anti-proliferating cell nuclear antigen (PCNA) murine monoclonal antibodies and human autoantibodies to the PCNA multiprotein complexes involved in cell proliferation. J Immunol 2001, 166:4780-4787.
12. Celis J.E., Madsen P., Nielsen H.V., Gesser B., Rasmussen H.H., Cruger D. Cyclin/PCNA is a cell cycle modulated nuclear protein with a role in DNA replication. Arch Biol Med Exp (Santiago ) 1988, 21:417-421.
13. Bravo R., Frank R., Blundell P.A., Macdonald-Bravo H. Cyclin/PCNA is the auxiliary protein of DNA polymerase-delta. Nature 1987, 326:515-517.
14. Moldovan G.L., Pfander B., Jentsch S. PCNA, the maestro of the replication fork. Cell 2007, 129:665-679.
15. Brand S.R., Bernstein R.M., Mathews M.B. Autoreactive epitope profiles of the proliferating cell nuclear antigen define two classes of autoantibodies. J Immunol 1994, 152:4120-4128.
16. Hsu T.C., Tsay G.J., Chen T.Y., Liu Y.C., Tzang B.S. Anti-PCNA autoantibodies preferentially recognize C-terminal of PCNA in patients with chronic hepatitis B virus infection. Clin Exp Immunol 2006, 144:110-116.
17. Kogure T., Takasaki Y., Takeuchi K., Yamada H., Nawata M., Ikeda K., et al. Autoimmune responses to proliferating cell nuclear antigen multiprotein complexes involved in cell proliferation are strongly associated with their structure and biologic function in patients with systemic lupus erythematosus. Arthritis Rheum 2002, 46:2946-2956.
18. Takasaki Y., Fishwild D., Tan E.M. Characterization of proliferating cell nuclear antigen recognized by autoantibodies in lupus sera. J Exp Med 1984, 159:981-992.
19. Fritzler M.J., McCarty G.A., Ryan J.P., Kinsella T.D. Clinical features of patients with antibodies directed against proliferating cell nuclear antigen. Arthritis Rheum 1983, 26:140-145.
20. Beyne-Rauzy O., Thebault S., Adoue D., Fortenfant F. Anti-PCNA antibodies: prevalence and predictive value. Joint Bone Spine 2005, 72:432-435.
21. Mahler M., Silverman E.D., Fritzler M.J. Novel diagnostic and clinical aspects of anti-PCNA antibodies detected by novel detection methods. Lupus 2010, 19:1527-1533.
22. Vermeersch P., De Beeck K.O., Lauwerys B.R., Van den Bergh K., Develter M., Marien G., et al. Antinuclear antibodies directed against proliferating cell nuclear antigen are not specifically associated with systemic lupus erythematosus. Ann Rheum Dis 2009, 68:1791-1793.
23. Tzang B.S., Chen T.Y., Hsu T.C., Liu Y.C., Tsay G.J. Presentation of autoantibody to proliferating cell nuclear antigen in patients with chronic hepatitis B and C virus infection. Ann Rheum Dis 1999, 58:630-634.
24. Takahashi T., Takasaki Y., Takeuchi K., Yamanaka K., Oshimi K., Hashimoto H. Detection of proliferating cell nuclear antigen (PCNA) in peripheral blood mononuclear cells and sera of patients with malignant lymphoma. Leuk Lymphoma 1997, 28:113-125.
25. Mahler M., Burlingame R.W., Wu J., Yang W., Fritzler M.J., Hanly J.G. Serological and clinical associations of anti-PCNA antibodies in systemic lupus erythematosus detected by a novel chemiluminescence assay. Arthritis Rheum (supplement) 2011, 63:898.
26. Yamasaki Y., Narain S., Yoshida H., Hernandez L., Barker T., Hahn P.C., et al. Autoantibodies to RNA helicase A: a new serologic marker of early lupus. Arthritis Rheum 2007, 56:596-604.
27. Takasaki Y., Ohgaki M., Kodama A., Ogata K., Hashimoto H., Shirai T., et al. A sandwich type enzyme-linked immunosorbent assay for proliferating cell nuclear antigen (PCNA)/cyclin using monoclonal antibodies. J Immunol Methods 1990, 132:227-237.
28. McBride J.D., Gabriel F.G., Fordham J., Kolind T., Barcenas-Morales G., Isenberg D.A., et al. Screening autoantibody profiles in systemic rheumatic disease with a diagnostic protein microarray that uses a filtration-assisted nanodot array luminometric immunoassay (NALIA). Clin Chem 2008, 54:883-890.
29. Damoiseaux J., Boesten K., Giesen J., Austen J., Tervaert J.W. Evaluation of a novel line-blot immunoassay for the detection of antibodies to extractable nuclear antigens. Ann N Y Acad Sci 2005, 1050:340-347.
30. Op De Beeck K., Vermeersch P., Verschueren P., Westhovens R., Mari+1/2n G., Blockmans D., et al. Detection of antinuclear antibodies by indirect immunofluorescence and by solid phase assay. Autoimmun Rev 2011, 10:801-808.
31. Mahler M., Radice A., Yang W., Bentow C., Seaman A., Bianchi L., et al. Development and performance evaluation of novel chemiluminescence assays for detection of anti-PR3 and anti-MPO antibodies. Clin Chim Acta 2012, 413:719-726.
32. Sherer Y., Gorstein A., Fritzler M.J., Shoenfeld Y. Autoantibody explosion in systemic lupus erythematosus: more than 100 different antibodies found in SLE patients. Semin Arthritis Rheum 2004, 34:501-537.
33. Mahler M., Ngo J.T., Schulte-Pelkum J., Luettich T., Fritzler M.J. Limited reliability of the indirect immunofluorescence technique for the detection of anti-Rib-P antibodies. Arthritis Res Ther 2008, 10:R131.
34. Kaneda K., Takasaki Y., Takeuchi K., Yamada H., Nawata M., Matsushita M., et al. Autoimmune response to proteins of proliferating cell nuclear antigen multiprotein complexes in patients with connective tissue diseases. J Rheumatol 2004, 31:2142-2150.
35. Maga G., Hubscher U. Proliferating cell nuclear antigen (PCNA): a dancer with many partners. J Cell Sci 2003, 116:3051-3060.
36. Kessenbrock K., Raijmakers R., Fritzler M.J., Mahler M. Synthetic peptides: the future of patient management in systemic rheumatic diseases?. Curr Med Chem 2007, 14:2831-2838.
37. Belizna C., Henrion D., Beucher A., Lavigne C., Ghaali A., Levesque H. Anti-Ku antibodies: Clinical, genetic and diagnostic insights. Autoimmun Rev 2010, 9:691-694.
38. Mahler M., Silverman E.D., Schulte-Pelkum J., Fritzler M.J. Anti-Scl-70 (topo-I) antibodies in SLE: Myth or reality?. Autoimmun Rev 2010, 9:756-760.
39. Sherer Y., Gorstein A., Fritzler M.J., Shoenfeld Y. Autoantibody explosion in systemic lupus erythematosus: more than 100 different antibodies found in SLE patients. Semin Arthritis Rheum 2004, 34:501-537.
40. Ghillani P., Andre C., Toly C., Rouquette A.M., Bengoufa D., Nicaise P., et al. Clinical significance of anti-Ro52 (TRIM21) antibodies non-associated with anti-SSA 60kDa antibodies: results of a multicentric study. Autoimmun Rev 2011, 10:509-513.